Insider NameBuy/SellCompany NameTickerAmountShares Change
Jun 16, 2025Jun 16, 2025Gorman Kevin Charles
Dir
SellXencor IncXNCR$9.22$29,255-14.37%
May 27, 2025May 29, 2025Gorman Kevin Charles
Dir
SellNeurocrine Biosciences IncNBIX$120.38$1M-1.83%
Feb 13, 2025Feb 14, 2025Gorman Kevin Charles
Dir
SellNeurocrine Biosciences IncNBIX$116.69$681,914-1.10%
Feb 10, 2025Feb 12, 2025Gorman Kevin Charles
Dir
SellNeurocrine Biosciences IncNBIX$118.37$269,167-0.44%
Jan 31, 2025Feb 04, 2025Gorman Kevin Charles
Dir
SellNeurocrine Biosciences IncNBIX$152.93$413,967-0.52%
Jan 27, 2025Jan 30, 2025Gorman Kevin Charles
Dir
SellNeurocrine Biosciences IncNBIX$149.46$22M-22.11%
Sep 27, 2024Oct 01, 2024Gorman Kevin Charles
Dir
SellXencor IncXNCR$20.68$54,885-24.03%
Feb 13, 2024Feb 15, 2024Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$133.02$376,700-0.55%
Feb 13, 2024Feb 15, 2024Gorman Kevin Charles
Dir
BuyXencor IncXNCR$19.12$1,013+1.04%
Feb 06, 2024Feb 09, 2024Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$138.74$737,271-1.04%
Jan 31, 2024Feb 03, 2024Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$140.69$380,845-0.54%
Jan 08, 2024Jan 10, 2024Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$133.02$22M-25.14%
Aug 21, 2023Aug 24, 2023Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$107.4$1M-1.83%
Feb 06, 2023Feb 09, 2023Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$102.9$3M-5.58%
Jan 31, 2023Feb 02, 2023Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$110.08$297,997-0.58%
Feb 07, 2022Feb 10, 2022Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$80.54$884,674-2.32%
Feb 05, 2021Feb 10, 2021Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$116.26$1M-2.77%
Jan 08, 2021Jan 12, 2021Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$110.22$34M-41.14%
Nov 12, 2020Nov 16, 2020Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$90.78$307,748-0.76%
Aug 05, 2020Aug 07, 2020Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$118.91$403,101-0.77%
Apr 24, 2020Apr 29, 2020Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$99.45$289,016-0.66%
Feb 07, 2020Feb 12, 2020Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$103.36$335,696-0.75%
Feb 05, 2020Feb 07, 2020Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$102.41$1M-2.23%
Aug 06, 2019Aug 08, 2019Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$95.31$8M-16.08%
Feb 06, 2019Feb 08, 2019Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$84.23$344,986-0.97%
Feb 04, 2019Feb 06, 2019Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$88.16$671,216-1.81%
May 01, 2018May 03, 2018Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$80.75$10M-26.77%
Feb 05, 2018Feb 07, 2018Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$80.25$9M-23.39%
Jan 16, 2018Jan 18, 2018Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$78.89$295,820-1.10%
May 02, 2017May 03, 2017Gorman Kevin Charles
CEO
SellNeurocrine Biosciences IncNBIX$53.23$1M-6.13%
Sign in to view more
To unlock more features with more data and insights.
Forgot your password?
By continuing, you agree to our Terms of Service and Privacy Policy.